Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction

Recommendation ID: IPG546/1
Question: Further research on angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction should provide clear details of patient selection. Efficacy outcomes should include procedural success (as measured by arterial imaging and blood-flow measurement), validated scoring systems of erectile dysfunction, and the duration of treatment effect. All complications should be reported. NICE may update the guidance on publication of further evidence.
Any explanatory notes (if applicable): Current evidence on the safety and efficacy of angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.

Source guidance details

Comes from guidance: Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction
Number: IPG546
Date issued: February 2016

Is this a recommendation for the use of a technology only in the context of research?	Yes
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	29/02/2016